Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Dyne Therapeutics, Inc.Listing unverified | Sell | $106.8K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $131K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $49.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $60.8K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $40.7K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Award | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $55.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $35.4K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Gift | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Gift | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Gift | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $911K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Gift | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $54.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Sell | $48K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Award | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $26.1K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $238.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $238.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $26.1K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $238.2K | SEC | |
Dyne Therapeutics, Inc.Listing unverified | Buy | $238.2K | SEC |